URYCVE traded at 2.34981 this Tuesday May 5th, decreasing 0.00113 or 0.05 percent since the previous trading session. Looking back, over the last four weeks, URYCVE lost 0.58 percent. Over the last 12 months, its price rose by 0.68 percent. Looking ahead, we forecast URYCVE to be priced at 2.34751 by the end of this quarter and at 2.36018 in one year, according to Trading Economics global macro models projections and analysts expectations.